http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-398358-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-896
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 1971-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-398358-A1
titleOfInvention PROCEDURE FOR OBTAINING INHIBITORS FOR GLYCOSID HYDROLAASES.
abstract Procedure for obtaining inhibitors for glycoside hydrolases, characterized in that it comprises cultivating a strain of actinomyces, especially actinoplanaceans and streptomycetaceae, in a culture medium; incubate the culture for 1 to 10 days, at a temperature of 15 to 60ºC, preferably 24-50ºC; separate the mycelium from the culture solution and, depending on the presentation of the inhibitors, the effective principle of the culture solution and/or the mycelium is enriched and separate the inhibitors from the culture broths by lyophilization or by precipitation with salts or solvents organic soluble in water or by adsorption of active substances on ion exchange agents. (Machine-translation by Google Translate, not legally binding)
priorityDate 1970-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 35.